Alterations in calcium homeostasis, autoimmune inflammatory processes, and blockade of nerve growth factor (NGF) mediated neuronal survival have also been implicated in peripheral neuropathy induced by bortezomib (Landowski et al., 2005; Yin et al., 2018). This evidence concerns the gene NGF and peripheral neuropathy.